<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Metabolic syndrome,Articles with unsourced statements since August 2007,ACE inhibitor,Acanthosis nigricans,Acquired,Adipocyte,Adiponectin,Adipose tissue,Adiposity,American Diabetes Association,Antiretroviral therapy" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Metabolic_syndrome&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Metabolic_syndrome&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Metabolic syndrome - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Metabolic_syndrome";
		var wgTitle = "Metabolic syndrome";
		var wgAction = "view";
		var wgArticleId = "54439";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 277276395;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Metabolic_syndrome skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Metabolic syndrome</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table class="infobox" width="200" cellspacing="0" style="font-size: 95%; text-align:left">
<tr>
<td style="text-align: center; background: lightgrey; font-size: 95%;" colspan="2"><b>Dysmetabolic syndrome X</b><br />
<i>Classification and external resources</i></td>
</tr>
<tr>
<th colspan="2" style="text-align: center; font-size: smaller;">
<div class="center">
<div class="floatnone"><a href="/wiki/File:Obesity6.JPG" class="image" title="Obesity6.JPG"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/b/b9/Obesity6.JPG/190px-Obesity6.JPG" width="190" height="95" border="0" /></a></div>
</div>
</th>
</tr>
<tr style="line-height: 1;">
<td colspan="2" style="text-align:center;"><small>An obese male. Weight 146 kg/322 lbs, height 177 cm/5 ft 10 in. The body mass index is 46.</small></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9</a></th>
<td><a href="http://www.icd9data.com/getICD9Code.ashx?icd9=277.7" class="external text" title="http://www.icd9data.com/getICD9Code.ashx?icd9=277.7" rel="nofollow">277.7</a></td>
</tr>
<tr>
<th><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=605552" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=605552" rel="nofollow">605552</a></td>
</tr>
<tr>
<th><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a href="http://www.diseasesdatabase.com/ddb31955.htm" class="external text" title="http://www.diseasesdatabase.com/ddb31955.htm" rel="nofollow">31955</a></td>
</tr>
<tr>
<th><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b></th>
<td><a href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D024821" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D024821" rel="nofollow">D024821</a></td>
</tr>
</table>
<p><b>Metabolic syndrome</b> is a combination of <a href="/wiki/Medicine" title="Medicine">medical</a> disorders that increase the risk of developing <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a> and <a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">diabetes</a>.<sup id="cite_ref-0" class="reference"><a href="#cite_note-0" title=""><span>[</span>1<span>]</span></a></sup> It affects one in five people, and prevalence increases with age. Some studies estimate the <a href="/wiki/Prevalence" title="Prevalence">prevalence</a> in the USA to be up to 25% of the population.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1" title=""><span>[</span>2<span>]</span></a></sup></p>
<p>Metabolic syndrome is also known as <b>metabolic syndrome X</b>, <b>syndrome X</b>, <b><a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a> syndrome</b>, <b><a href="/wiki/Gerald_Reaven" title="Gerald Reaven">Reaven</a>'s syndrome</b>, and <b>CHAOS</b> (Australia)<sup id="cite_ref-2" class="reference"><a href="#cite_note-2" title=""><span>[</span>3<span>]</span></a></sup>. A similar condition in overweight horses is referred to as <a href="/wiki/Equine_metabolic_syndrome" title="Equine metabolic syndrome">equine metabolic syndrome</a>; it is unknown if they have the same <a href="/wiki/Etiology" title="Etiology">etiology</a>.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#Etiology"><span class="tocnumber">2</span> <span class="toctext">Etiology</span></a></li>
<li class="toclevel-1"><a href="#Pathophysiology"><span class="tocnumber">3</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1"><a href="#Risk_Factors"><span class="tocnumber">4</span> <span class="toctext">Risk Factors</span></a>
<ul>
<li class="toclevel-2"><a href="#Overweight_and_Obesity"><span class="tocnumber">4.1</span> <span class="toctext">Overweight and Obesity</span></a></li>
<li class="toclevel-2"><a href="#Sedentary_Lifestyle"><span class="tocnumber">4.2</span> <span class="toctext">Sedentary Lifestyle</span></a></li>
<li class="toclevel-2"><a href="#Aging"><span class="tocnumber">4.3</span> <span class="toctext">Aging</span></a></li>
<li class="toclevel-2"><a href="#Diabetes_Mellitus"><span class="tocnumber">4.4</span> <span class="toctext">Diabetes Mellitus</span></a></li>
<li class="toclevel-2"><a href="#Coronary_Heart_Disease"><span class="tocnumber">4.5</span> <span class="toctext">Coronary Heart Disease</span></a></li>
<li class="toclevel-2"><a href="#Lipodystrophy"><span class="tocnumber">4.6</span> <span class="toctext">Lipodystrophy</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Signs_and_symptoms"><span class="tocnumber">5</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1"><a href="#Diagnosis"><span class="tocnumber">6</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2"><a href="#WHO"><span class="tocnumber">6.1</span> <span class="toctext">WHO</span></a></li>
<li class="toclevel-2"><a href="#EGIR"><span class="tocnumber">6.2</span> <span class="toctext">EGIR</span></a></li>
<li class="toclevel-2"><a href="#NCEP"><span class="tocnumber">6.3</span> <span class="toctext">NCEP</span></a></li>
<li class="toclevel-2"><a href="#American_Heart_Association.2FUpdated_NCEP"><span class="tocnumber">6.4</span> <span class="toctext">American Heart Association/Updated NCEP</span></a></li>
<li class="toclevel-2"><a href="#Other"><span class="tocnumber">6.5</span> <span class="toctext">Other</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Prevention"><span class="tocnumber">7</span> <span class="toctext">Prevention</span></a></li>
<li class="toclevel-1"><a href="#Therapy"><span class="tocnumber">8</span> <span class="toctext">Therapy</span></a></li>
<li class="toclevel-1"><a href="#Controversy"><span class="tocnumber">9</span> <span class="toctext">Controversy</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">10</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">11</span> <span class="toctext">References</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=1" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>The term "metabolic syndrome" dates back to at least the late 1950s, but came into common usage in the late 1970s to describe various associations of risk factors with diabetes, that had been noted as early as the 1920s.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3" title=""><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-4" class="reference"><a href="#cite_note-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<ul>
<li>The Marseilles physician Dr. Jean Vague, in 1947, observed that upper body obesity appeared to predispose to <a href="/wiki/Diabetes" title="Diabetes" class="mw-redirect">diabetes</a>, <a href="/wiki/Atherosclerosis" title="Atherosclerosis">atherosclerosis</a>, gout, and <a href="/wiki/Calculi" title="Calculi" class="mw-redirect">calculi</a>.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5" title=""><span>[</span>6<span>]</span></a></sup></li>
<li>Avogaro, Crepaldi and co-workers described six moderately obese patients with diabetes, hypercholesterolemia, and marked hypertriglyceridemia all of which improved when the patients were put on a hypocaloric, low carbohydrate diet.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6" title=""><span>[</span>7<span>]</span></a></sup></li>
<li>In 1977, Haller used the term "metabolic syndrome" for associations of obesity, diabetes mellitus, hyperlipoproteinemia, hyperuricemia and <a href="/w/index.php?title=Steatosis_hepatis&amp;action=edit&amp;redlink=1" class="new" title="Steatosis hepatis (page does not exist)">steatosis hepatis</a> when describing the additive effects of risk factors on atherosclerosis.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7" title=""><span>[</span>8<span>]</span></a></sup></li>
<li>The same year, Singer used the term for associations of obesity, gout, diabetes mellitus, and hypertension with hyperlipoprotenemia.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8" title=""><span>[</span>9<span>]</span></a></sup></li>
<li>In 1977 and 1978, Gerald B. Phillips developed the concept that risk factors for myocardial infarction concur to form a "constellation of abnormalities" (i.e., glucose intolerance, hyperinsulinemia, hyperlipidemia [hypercholesterolemia and hypertriglyceridemia] and hypertension) that is associated not only with heart disease, but also with aging, obesity and other clinical states. He suggested there must be an underlying linking factor, the identification of which could lead to the prevention of cardiovascular disease; he hypothesized that this factor was sex hormones.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9" title=""><span>[</span>10<span>]</span></a></sup><sup id="cite_ref-10" class="reference"><a href="#cite_note-10" title=""><span>[</span>11<span>]</span></a></sup></li>
<li>In 1988, in his Banting lecture, <a href="/wiki/Gerald_M._Reaven" title="Gerald M. Reaven" class="mw-redirect">Gerald M. Reaven</a> proposed insulin resistance as the underlying factor and named the constellation of abnormalities Syndrome X. Reaven did not include abdominal obesity, which has also been hypothesized as the underlying factor, as part of the condition.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11" title=""><span>[</span>12<span>]</span></a></sup></li>
</ul>
<p>The terms "metabolic syndrome," "insulin resistance syndrome," and "syndrome X" are now used specifically to define a constellation of abnormalities that is associated with increased risk for the development of type 2 diabetes and atherosclerotic vascular disease (e.g. heart disease and stroke).</p>
<p><a name="Etiology" id="Etiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=2" title="Edit section: Etiology">edit</a>]</span> <span class="mw-headline">Etiology</span></h2>
<p>The exact mechanisms of the complex pathways of metabolic syndrome are not yet completely known. The pathophysiology is extremely complex and has been only partially elucidated. Most patients are older, obese, sedentary, and have a degree of <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a>. The most important factors in order are:</p>
<ol>
<li>weight,</li>
<li>aging,</li>
<li>genetics, and</li>
<li>lifestyle, i.e., low physical activity and excess caloric intake.</li>
</ol>
<p>There is debate regarding whether obesity or insulin resistance is the <i>cause</i> of the metabolic syndrome or if they are consequences of a more far-reaching metabolic derangement. A number of markers of systemic <a href="/wiki/Inflammation" title="Inflammation">inflammation</a>, including <a href="/wiki/C-reactive_protein" title="C-reactive protein">C-reactive protein</a>, are often increased, as are <a href="/wiki/Fibrinogen" title="Fibrinogen" class="mw-redirect">fibrinogen</a>, <a href="/wiki/Interleukin_6" title="Interleukin 6">interleukin 6</a> (IL–6), <a href="/wiki/Tumor_necrosis_factor-alpha" title="Tumor necrosis factor-alpha">Tumor necrosis factor-alpha</a> (TNFα) and others. Some have pointed to <a href="/wiki/Oxidative_stress" title="Oxidative stress">oxidative stress</a> due to a variety of causes including increased uric acid levels caused by dietary <a href="/wiki/Fructose" title="Fructose">fructose</a>.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12" title=""><span>[</span>13<span>]</span></a></sup><sup id="cite_ref-13" class="reference"><a href="#cite_note-13" title=""><span>[</span>14<span>]</span></a></sup><sup id="cite_ref-14" class="reference"><a href="#cite_note-14" title=""><span>[</span>15<span>]</span></a></sup></p>
<p><a name="Pathophysiology" id="Pathophysiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=3" title="Edit section: Pathophysiology">edit</a>]</span> <span class="mw-headline">Pathophysiology</span></h2>
<p>Commonly there is development of <a href="/wiki/Visceral_fat" title="Visceral fat" class="mw-redirect">visceral fat</a> after which the <a href="/wiki/Adipocyte" title="Adipocyte">adipocytes</a> (fat <a href="/wiki/Cell_(biology)" title="Cell (biology)">cells</a>) of the visceral fat increase <a href="/wiki/Blood_plasma" title="Blood plasma">plasma</a> levels of TNFα and alter levels of a number of other substances (e.g., <a href="/wiki/Adiponectin" title="Adiponectin">adiponectin</a>, <a href="/wiki/Resistin" title="Resistin">resistin</a>, <a href="/wiki/PAI-1" title="PAI-1" class="mw-redirect">PAI-1</a>). TNFα has been shown not only to cause the production of inflammatory <a href="/wiki/Cytokine" title="Cytokine">cytokines</a>, but possibly to trigger cell signalling by interaction with a TNFα <a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptor</a> that may lead to insulin resistance<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since August 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>. An experiment with rats that were fed a diet one-third of which was <a href="/wiki/Sucrose" title="Sucrose">sucrose</a> has been proposed as a model for the development of the metabolic syndrome. The sucrose first elevated blood levels of <a href="/wiki/Triglyceride" title="Triglyceride">triglycerides</a>, which induced <a href="/wiki/Visceral" title="Visceral" class="mw-redirect">visceral</a> fat and ultimately resulted in insulin resistance <sup id="cite_ref-15" class="reference"><a href="#cite_note-15" title=""><span>[</span>16<span>]</span></a></sup>. The progression from visceral fat to increased TNFα to insulin resistance has some parallels to human development of metabolic syndrome.</p>
<p><a name="Risk_Factors" id="Risk_Factors"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=4" title="Edit section: Risk Factors">edit</a>]</span> <span class="mw-headline">Risk Factors</span></h2>
<p><a name="Overweight_and_Obesity" id="Overweight_and_Obesity"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=5" title="Edit section: Overweight and Obesity">edit</a>]</span> <span class="mw-headline">Overweight and Obesity</span></h3>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Central_obesity" title="Central obesity" class="mw-redirect">Central obesity</a></div>
<p><a href="/wiki/Central_obesity" title="Central obesity" class="mw-redirect">Central adiposity</a> is a key feature of the syndrome, reflecting the fact that the syndrome's prevalence is driven by the strong relationship between <a href="/wiki/Waist" title="Waist">waist</a> <a href="/wiki/Circumference" title="Circumference">circumference</a> and increasing <a href="/wiki/Adiposity" title="Adiposity" class="mw-redirect">adiposity</a>. However, despite the importance of <a href="/wiki/Obesity" title="Obesity">obesity</a>, patients who are normal weight may also be <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin-resistant</a> and have the syndrome.<sup id="cite_ref-isbn0-07-147692-X_16-0" class="reference"><a href="#cite_note-isbn0-07-147692-X-16" title=""><span>[</span>17<span>]</span></a></sup></p>
<p><a name="Sedentary_Lifestyle" id="Sedentary_Lifestyle"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=6" title="Edit section: Sedentary Lifestyle">edit</a>]</span> <span class="mw-headline">Sedentary Lifestyle</span></h3>
<p><a href="/wiki/Sedentary_lifestyle" title="Sedentary lifestyle">Physical inactivity</a> is a predictor of <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">CVD</a> events and related <a href="/wiki/Death" title="Death">mortality</a>. Many components of the metabolic syndrome are associated with a <a href="/wiki/Sedentary_lifestyle" title="Sedentary lifestyle">sedentary lifestyle</a>, including increased <a href="/wiki/Adipose_tissue" title="Adipose tissue">adipose tissue</a> (predominantly <a href="/wiki/Central_obesity" title="Central obesity" class="mw-redirect">central</a>); reduced <a href="/wiki/HDL_cholesterol" title="HDL cholesterol" class="mw-redirect">HDL cholesterol</a>; and a trend toward increased <a href="/wiki/Triglycerides" title="Triglycerides" class="mw-redirect">triglycerides</a>, <a href="/wiki/Hypertension" title="Hypertension">blood pressure</a>, and <a href="/wiki/Glucose" title="Glucose">glucose</a> in the genetically susceptible. Compared with individuals who watched <a href="/wiki/Television" title="Television">television</a> or <a href="/wiki/Videos" title="Videos" class="mw-redirect">videos</a> or used their <a href="/wiki/Computer" title="Computer">computer</a> &lt;1 h daily, those who carried out these behaviors for &gt;4 h daily have a twofold increased <a href="/wiki/Risk" title="Risk">risk</a> of the metabolic syndrome.<sup id="cite_ref-isbn0-07-147692-X_16-1" class="reference"><a href="#cite_note-isbn0-07-147692-X-16" title=""><span>[</span>17<span>]</span></a></sup></p>
<p><a name="Aging" id="Aging"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=7" title="Edit section: Aging">edit</a>]</span> <span class="mw-headline">Aging</span></h3>
<p>The metabolic syndrome affects 44% of the U.S. population older than age 50. A greater percentage of women older than age 50 have the syndrome than men. The age dependency of the syndrome's prevalence is seen in most populations around the world.<sup id="cite_ref-isbn0-07-147692-X_16-2" class="reference"><a href="#cite_note-isbn0-07-147692-X-16" title=""><span>[</span>17<span>]</span></a></sup></p>
<p><a name="Diabetes_Mellitus" id="Diabetes_Mellitus"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=8" title="Edit section: Diabetes Mellitus">edit</a>]</span> <span class="mw-headline">Diabetes Mellitus</span></h3>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Diabetes_Mellitus" title="Diabetes Mellitus" class="mw-redirect">Diabetes Mellitus</a></div>
<p>It is estimated that the large majority (~75%) of patients with <a href="/wiki/Type_2_diabetes" title="Type 2 diabetes" class="mw-redirect">type 2 diabetes</a> or <a href="/wiki/Impaired_glucose_tolerance" title="Impaired glucose tolerance">impaired glucose tolerance</a> (<a href="/wiki/Impaired_glucose_tolerance" title="Impaired glucose tolerance">IGT</a>) have the metabolic syndrome. The presence of the metabolic syndrome in these populations is associated with a higher prevalence of CVD than found in patients with type 2 diabetes or IGT without the syndrome.<sup id="cite_ref-isbn0-07-147692-X_16-3" class="reference"><a href="#cite_note-isbn0-07-147692-X-16" title=""><span>[</span>17<span>]</span></a></sup> <a href="/wiki/Adiponectin#Hypoadiponectinemia" title="Adiponectin">Hypoadiponectinemia</a> has been shown to increase <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a><sup id="cite_ref-pmid17495599_17-0" class="reference"><a href="#cite_note-pmid17495599-17" title=""><span>[</span>18<span>]</span></a></sup>, and is considered to be a <a href="/wiki/Risk_factor" title="Risk factor">risk factor</a> for developing metabolic syndrome.<sup id="cite_ref-pmid19258676_18-0" class="reference"><a href="#cite_note-pmid19258676-18" title=""><span>[</span>19<span>]</span></a></sup></p>
<p><a name="Coronary_Heart_Disease" id="Coronary_Heart_Disease"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=9" title="Edit section: Coronary Heart Disease">edit</a>]</span> <span class="mw-headline">Coronary Heart Disease</span></h3>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Coronary_disease" title="Coronary disease">Coronary disease</a></div>
<p>The approximate prevalence of the metabolic syndrome in patients with <a href="/wiki/Coronary_heart_disease" title="Coronary heart disease" class="mw-redirect">coronary heart disease</a> (<a href="/wiki/Coronary_disease" title="Coronary disease">CHD</a>) is 50%, with a prevalence of 37% in patients with premature <a href="/wiki/Coronary_artery_disease" title="Coronary artery disease">coronary artery disease</a> ( age 45), particularly in women. With appropriate <a href="/wiki/Cardiopulmonary_Rehabilitation" title="Cardiopulmonary Rehabilitation" class="mw-redirect">cardiac rehabilitation</a> and changes in <a href="/wiki/Lifestyle" title="Lifestyle">lifestyle</a> (e.g., <a href="/wiki/Nutrition" title="Nutrition">nutrition</a>, <a href="/wiki/Physical_activity" title="Physical activity" class="mw-redirect">physical activity</a>, <a href="/wiki/Weight" title="Weight">weight</a> reduction, and, in some cases, <a href="/wiki/Drugs" title="Drugs" class="mw-redirect">Drugs</a>), the prevalence of the syndrome can be reduced.<sup id="cite_ref-isbn0-07-147692-X_16-4" class="reference"><a href="#cite_note-isbn0-07-147692-X-16" title=""><span>[</span>17<span>]</span></a></sup></p>
<p><a name="Lipodystrophy" id="Lipodystrophy"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=10" title="Edit section: Lipodystrophy">edit</a>]</span> <span class="mw-headline">Lipodystrophy</span></h3>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Lipodystrophy" title="Lipodystrophy">Lipodystrophy</a></div>
<p>Lipodystrophic disorders in general are associated with the metabolic syndrome. Both genetic (e.g., <a href="/wiki/Berardinelli-Seip_congenital_lipodystrophy" title="Berardinelli-Seip congenital lipodystrophy">Berardinelli-Seip congenital lipodystrophy</a>, <a href="/wiki/Dunnigan_familial_partial_lipodystrophy" title="Dunnigan familial partial lipodystrophy">Dunnigan familial partial lipodystrophy</a>) and <a href="/wiki/Acquired" title="Acquired" class="mw-redirect">acquired</a> (e.g., <a href="/wiki/HIV" title="HIV">HIV</a>-related <a href="/wiki/Lipodystrophy" title="Lipodystrophy">lipodystrophy</a> in patients treated with highly active <a href="/wiki/Antiretroviral_therapy" title="Antiretroviral therapy" class="mw-redirect">antiretroviral therapy</a>) forms of lipodystrophy may give rise to severe <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a> and many of the metabolic syndrome's components.<sup id="cite_ref-isbn0-07-147692-X_16-5" class="reference"><a href="#cite_note-isbn0-07-147692-X-16" title=""><span>[</span>17<span>]</span></a></sup></p>
<p><a name="Signs_and_symptoms" id="Signs_and_symptoms"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=11" title="Edit section: Signs and symptoms">edit</a>]</span> <span class="mw-headline">Signs and symptoms</span></h2>
<p>Symptoms and features are:</p>
<ul>
<li>Fasting hyperglycemia — <a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">diabetes mellitus type 2</a> or <a href="/wiki/Impaired_fasting_glucose" title="Impaired fasting glucose" class="mw-redirect">impaired fasting glucose</a>, <a href="/wiki/Impaired_glucose_tolerance" title="Impaired glucose tolerance">impaired glucose tolerance</a>, or <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a>;</li>
<li><a href="/wiki/High_blood_pressure" title="High blood pressure" class="mw-redirect">High blood pressure</a>;</li>
<li><a href="/wiki/Central_obesity" title="Central obesity" class="mw-redirect">Central obesity</a> (also known as visceral, male-pattern or apple-shaped adiposity), overweight with fat deposits mainly around the waist;</li>
<li>Decreased <a href="/wiki/High_density_lipoprotein" title="High density lipoprotein" class="mw-redirect">HDL</a> cholesterol;</li>
<li>Elevated <a href="/wiki/Triglyceride" title="Triglyceride">triglycerides</a>;</li>
</ul>
<p>Associated diseases and signs are: <a href="/wiki/Hyperuricemia" title="Hyperuricemia">hyperuricemia</a>, <a href="/wiki/Fatty_liver" title="Fatty liver">fatty liver</a> (especially in concurrent <a href="/wiki/Obesity" title="Obesity">obesity</a>) progressing to <a href="/wiki/Non-alcoholic_fatty_liver_disease" title="Non-alcoholic fatty liver disease">non-alcoholic fatty liver disease</a>, <a href="/wiki/Polycystic_ovarian_syndrome" title="Polycystic ovarian syndrome" class="mw-redirect">polycystic ovarian syndrome</a> (in women), and <a href="/wiki/Acanthosis_nigricans" title="Acanthosis nigricans">acanthosis nigricans</a>.</p>
<p><a name="Diagnosis" id="Diagnosis"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=12" title="Edit section: Diagnosis">edit</a>]</span> <span class="mw-headline">Diagnosis</span></h2>
<p>There are currently two major definitions for metabolic syndrome provided by the <a href="/wiki/International_Diabetes_Federation" title="International Diabetes Federation">International Diabetes Federation</a><sup id="cite_ref-19" class="reference"><a href="#cite_note-19" title=""><span>[</span>20<span>]</span></a></sup> and the revised <a href="/wiki/National_Cholesterol_Education_Program" title="National Cholesterol Education Program">National Cholesterol Education Program</a>, respectively. The revised NCEP and IDF definitions of metabolic syndrome are very similar and it can be expected that they will identify many of the same individuals as having metabolic syndrome. The two differences are that IDF excludes any subject without increased waist circumference, while in the NCEP definition metabolic syndrome can be diagnosed based on other criteria and the IDF uses geography-specific cut points for waist circumference, while NCEP uses only one set of cut points for waist circumference regardless of geography. These two definitions are much closer to each other than the original NCEP and WHO definitions.</p>
<p><a name="WHO" id="WHO"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=13" title="Edit section: WHO">edit</a>]</span> <span class="mw-headline">WHO</span></h3>
<p>The <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> criteria (1999) require presence of diabetes mellitus, impaired glucose tolerance, impaired fasting glucose or insulin resistance, AND two of the following:</p>
<ul>
<li>blood pressure: ≥ 140/90 mmHg</li>
<li>dyslipidaemia: triglycerides (TG): ≥ 1.695 mmol/L and high-density lipoprotein cholesterol (HDL-C) ≤ 0.9 mmol/L (male), ≤ 1.0 mmol/L (female)</li>
<li>central obesity: waist:hip ratio &gt; 0.90 (male); &gt; 0.85 (female), and/or body mass index &gt; 30 kg/m<sup>2</sup></li>
<li>microalbuminuria: urinary albumin excretion ratio ≥ 20 mg/min or albumin:creatinine ratio ≥ 30 mg/g</li>
</ul>
<p><a name="EGIR" id="EGIR"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=14" title="Edit section: EGIR">edit</a>]</span> <span class="mw-headline">EGIR</span></h3>
<p>The <a href="/w/index.php?title=European_Group_for_the_Study_of_Insulin_Resistance&amp;action=edit&amp;redlink=1" class="new" title="European Group for the Study of Insulin Resistance (page does not exist)">European Group for the Study of Insulin Resistance</a> (1999) requires insulin resistance defined as the top 25% of the fasting insulin values among non-diabetic individuals AND two or more of the following:</p>
<ul>
<li>central obesity: waist circumference ≥ 94 cm (male), ≥ 80 cm (female)</li>
<li>dyslipidaemia: TG ≥ 2.0 mmol/L and/or HDL-C &lt; 1.0 mmol/L or treated for dyslipidaemia</li>
<li>hypertension: blood pressure ≥ 140/90 mmHg or antihypertensive medication</li>
<li>fasting plasma glucose ≥ 6.1 mmol/L</li>
</ul>
<p><a name="NCEP" id="NCEP"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=15" title="Edit section: NCEP">edit</a>]</span> <span class="mw-headline">NCEP</span></h3>
<p>The US National Cholesterol Education Program Adult Treatment Panel III (2001) requires at least three of the following:<sup id="cite_ref-20" class="reference"><a href="#cite_note-20" title=""><span>[</span>21<span>]</span></a></sup></p>
<ul>
<li>central obesity: waist circumference ≥ 102 cm or 40 inches (male), ≥ 88 cm or 36 inches(female)</li>
<li>dyslipidaemia: TG ≥ 1.695 mmol/L (150 mg/dl)</li>
<li>dyslipidaemia: HDL-C &lt; 40 mg/dL (male), &lt; 50 mg/dL (female)</li>
<li>blood pressure ≥ 130/85 mmHg</li>
<li>fasting plasma glucose ≥ 6.1 mmol/L (110 mg/dl)</li>
</ul>
<p><a name="American_Heart_Association.2FUpdated_NCEP" id="American_Heart_Association.2FUpdated_NCEP"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=16" title="Edit section: American Heart Association/Updated NCEP">edit</a>]</span> <span class="mw-headline">American Heart Association/Updated NCEP</span></h3>
<p>There is confusion as to whether AHA/NHLBI intended to create another set of guidelines or simply update the NCEP ATP III definition. According to Scott Grundy, University of Texas Southwestern Medical School, Dallas, Texas, the intent was just to update the NCEP ATP III definition and not create a new definition.<sup id="cite_ref-Grundy_21-0" class="reference"><a href="#cite_note-Grundy-21" title=""><span>[</span>22<span>]</span></a></sup><sup id="cite_ref-22" class="reference"><a href="#cite_note-22" title=""><span>[</span>23<span>]</span></a></sup>:</p>
<ul>
<li>Elevated waist circumference:
<ul>
<li>Men — Equal to or greater than 40 inches (102 cm)</li>
<li>Women — Equal to or greater than 35 inches (88 cm)</li>
</ul>
</li>
<li>Elevated triglycerides: Equal to or greater than 150 mg/dL</li>
<li>Reduced HDL (“good”) cholesterol:
<ul>
<li>Men — Less than 40 mg/dL</li>
<li>Women — Less than 50 mg/dL</li>
</ul>
</li>
<li>Elevated blood pressure: Equal to or greater than 130/85 mm Hg or use of medication for hypertension</li>
<li>Elevated fasting glucose: Equal to or greater than 100 mg/dL (5.6 mmol/L) or use of medication for hyperglycemia</li>
</ul>
<p><a name="Other" id="Other"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=17" title="Edit section: Other">edit</a>]</span> <span class="mw-headline">Other</span></h3>
<p><a href="/wiki/C-reactive_protein" title="C-reactive protein">High-sensitivity C-reactive protein</a> (<a href="/wiki/C-reactive_protein" title="C-reactive protein">hs-CRP</a>) has been developed and used as a marker to predict coronary vascular diseases in metabolic syndrome, and it was recently used predictor for <a href="/wiki/Non-alcoholic_fatty_liver_disease" title="Non-alcoholic fatty liver disease">non-alcoholic fatty liver disease</a> in correlation with serum markers that indicated lipid and glucose metabolism.<sup id="cite_ref-pmid19271113_23-0" class="reference"><a href="#cite_note-pmid19271113-23" title=""><span>[</span>24<span>]</span></a></sup></p>
<p><a name="Prevention" id="Prevention"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=18" title="Edit section: Prevention">edit</a>]</span> <span class="mw-headline">Prevention</span></h2>
<p>Various strategies have been proposed to prevent the development of metabolic syndrome. These include increased physical activity (such as walking 30 minutes every day),<sup id="cite_ref-24" class="reference"><a href="#cite_note-24" title=""><span>[</span>25<span>]</span></a></sup> and a healthy, reduced calorie diet.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25" title=""><span>[</span>26<span>]</span></a></sup> There are many studies that support the value of a healthy lifestyle as above. However, one study stated that these measures are effective in only a minority of people, primarily due to a lack of compliance with lifestyle and diet changes.<sup id="cite_ref-katzmaryk_26-0" class="reference"><a href="#cite_note-katzmaryk-26" title=""><span>[</span>27<span>]</span></a></sup> The <a href="/wiki/International_Obesity_Taskforce" title="International Obesity Taskforce">International Obesity Taskforce</a> states that interventions on a sociopolitical level are required to reduce development of the metabolic syndrome in populations.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27" title=""><span>[</span>28<span>]</span></a></sup></p>
<p>A 2007 study of 2,375 male subjects over 20 years suggested that daily intake of a pint of milk or equivalent dairy products more than halved the risk of metabolic syndrome.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28" title=""><span>[</span>29<span>]</span></a></sup> Other studies both support and dispute the authors' findings.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29" title=""><span>[</span>30<span>]</span></a></sup></p>
<p><a name="Therapy" id="Therapy"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=19" title="Edit section: Therapy">edit</a>]</span> <span class="mw-headline">Therapy</span></h2>
<p>The first line treatment is change of lifestyle (i.e., caloric restriction and physical activity). However, drug treatment is frequently required. Generally, the individual disorders that comprise the metabolic syndrome are treated separately. <a href="/wiki/Diuretic" title="Diuretic">Diuretics</a> and <a href="/wiki/ACE_inhibitor" title="ACE inhibitor">ACE inhibitors</a> may be used to treat <a href="/wiki/Hypertension" title="Hypertension">hypertension</a>. Cholesterol drugs may be used to lower LDL cholesterol and triglyceride levels, if they are elevated, and to raise HDL levels if they are low. Use of drugs that decrease <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a>, e.g., <a href="/wiki/Metformin" title="Metformin">metformin</a> and <a href="/wiki/Thiazolidinedione" title="Thiazolidinedione">thiazolidinediones</a>, is controversial; this treatment is not approved by the <a href="/wiki/U.S._Food_and_Drug_Administration" title="U.S. Food and Drug Administration">U.S. Food and Drug Administration</a>.</p>
<p>A 2003 study indicated that cardiovascular exercise was therapeutic in approximately 31% of cases. The most probable benefit was to triglyceride levels, with 43% showing improvement; but fasting plasma glucose and insulin resistance of 91% of test subjects did not improve.<sup id="cite_ref-katzmaryk_26-1" class="reference"><a href="#cite_note-katzmaryk-26" title=""><span>[</span>27<span>]</span></a></sup> Many other studies have supported the value of increased physical activity and restricted caloric intake (exercise and diet) to treat metabolic syndrome.</p>
<p><a name="Controversy" id="Controversy"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=20" title="Edit section: Controversy">edit</a>]</span> <span class="mw-headline">Controversy</span></h2>
<p>The clinical value of the metabolic syndrome has recently come under fire. It is asserted that different sets of conflicting and incomplete diagnostic criteria are in existence, and that diagnosis of the metabolic syndrome has a negligible association with the risk of heart disease.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30" title=""><span>[</span>31<span>]</span></a></sup></p>
<p>These concerns have led to the <a href="/wiki/American_Diabetes_Association" title="American Diabetes Association">American Diabetes Association</a> and the <a href="/wiki/European_Association_for_the_Study_of_Diabetes" title="European Association for the Study of Diabetes">European Association for the Study of Diabetes</a> to issue a joint statement identifying eight major concerns on the clinical utility of the metabolic syndrome.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31" title=""><span>[</span>32<span>]</span></a></sup></p>
<p>It is not contested that cardiovascular risk factors tend to cluster together, but what is contested is the assertion that the metabolic syndrome is anything more than the sum of its constituent parts.</p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=21" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="/wiki/Hyperinsulinemia" title="Hyperinsulinemia">Hyperinsulinemia</a></li>
<li><a href="/wiki/Insulin_resistance" title="Insulin resistance">Insulin resistance</a></li>
<li><a href="/wiki/Chronic_Somogyi_rebound" title="Chronic Somogyi rebound">Chronic Somogyi rebound</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=22" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-0"><b><a href="#cite_ref-0" title="">^</a></b> <a href="http://www.nlm.nih.gov/medlineplus/metabolicsyndrome.html" class="external text" title="http://www.nlm.nih.gov/medlineplus/metabolicsyndrome.html" rel="nofollow">MedlinePlus: Metabolic Syndrome</a></li>
<li id="cite_note-1"><b><a href="#cite_ref-1" title="">^</a></b> Ford ES, Giles WH, Dietz WH (2002). Prevalence of metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. <i>JAMA</i> <b>287</b>(3):356-359. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11790215" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11790215">PMID 11790215</a></li>
<li id="cite_note-2"><b><a href="#cite_ref-2" title="">^</a></b> In his <a href="http://www.agale.com.au/CFS.htm" class="external text" title="http://www.agale.com.au/CFS.htm" rel="nofollow">case studies poster</a> presented at the Chronic Fatigue Syndrome Conference in Sydney, Australia (February 12-13, 1998), Dr Allen E. Gale, Consultant Physician (Allergy), identifies the acronym CHAOS as an abbreviation for Coronary artery disease, Hypertension, Atherosclerosis, Obesity, and Stroke.</li>
<li id="cite_note-3"><b><a href="#cite_ref-3" title="">^</a></b> Joslin EP. The prevention of diabetes mellitus. <i>JAMA</i> 1921;76:79–84.</li>
<li id="cite_note-4"><b><a href="#cite_ref-4" title="">^</a></b> Kylin E. [Studies of the hypertension-hyperglycemia-hyperuricemia syndrome] (German). <i>Zentralbl Inn Med</i> 1923;44: 105-27.</li>
<li id="cite_note-5"><b><a href="#cite_ref-5" title="">^</a></b> Vague J. La diffférenciacion sexuelle, facteur déterminant des formes de l'obésité. Presse Med 1947;30:339-40.</li>
<li id="cite_note-6"><b><a href="#cite_ref-6" title="">^</a></b> Avogaro P, Crepaldi G, Enzi G, Tiengo A. Associazione di iperlipidemia, diabete mellito e obesità di medio grado. <i>Acta Diabetol Lat</i> 1967;4:572-590.</li>
<li id="cite_note-7"><b><a href="#cite_ref-7" title="">^</a></b> Haller H. [Epidemiology and associated risk factors of hyperlipoproteinemia] (German). <i>Z Gesamte Inn Med</i> 1977;32(8):124-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/883354" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/883354">PMID 883354</a>.</li>
<li id="cite_note-8"><b><a href="#cite_ref-8" title="">^</a></b> Singer P. [Diagnosis of primary hyperlipoproteinemias] (German). <i>Z Gesamte Inn Med</i> 1977;32(9):129-33. <a href="http://www.ncbi.nlm.nih.gov/pubmed/906591" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/906591">PMID 906591</a>.</li>
<li id="cite_note-9"><b><a href="#cite_ref-9" title="">^</a></b> Phillips GB. Sex hormones, risk factors and cardiovascular disease. <i>Am J Med</i> 1978;65:7-11. <a href="http://www.ncbi.nlm.nih.gov/pubmed/356599" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/356599">PMID 356599</a>.</li>
<li id="cite_note-10"><b><a href="#cite_ref-10" title="">^</a></b> Phillips GB. Relationship between serum sex hormones and glucose, insulin, and lipid abnormalities in men with myocardial infarction. <i>Proc Natl Acad Sci U S A</i> 1977;74:1729-1733. <a href="http://www.ncbi.nlm.nih.gov/pubmed/193114" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/193114">PMID 193114</a>.</li>
<li id="cite_note-11"><b><a href="#cite_ref-11" title="">^</a></b> Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607. <a href="http://www.ncbi.nlm.nih.gov/pubmed/3056758" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/3056758">PMID 3056758</a>.</li>
<li id="cite_note-12"><b><a href="#cite_ref-12" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNakagawa_T.2C_Hu_H.2C_Zharikov_S.2C_Tuttle_KR.2C_Short_RA.2C_Glushakova_O.2C_Ouyang_X.2C_Feig_DI.2C_Block_ER.2C_Herrera-Acosta_J.2C_Patel_JM.2C_Johnson_RJ2006">Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ (2006). "A causal role for uric acid in fructose-induced metabolic syndrome". <i>Am J Phys Renal Phys</i> <b>290</b> (3): F625–F631. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1152%2Fajprenal.00140.2005" class="external text" title="http://dx.doi.org/10.1152%2Fajprenal.00140.2005" rel="nofollow">10.1152/ajprenal.00140.2005</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16234313" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16234313">PMID 16234313</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+causal+role+for+uric+acid+in+fructose-induced+metabolic+syndrome&amp;rft.jtitle=Am+J+Phys+Renal+Phys&amp;rft.aulast=Nakagawa+T%2C+Hu+H%2C+Zharikov+S%2C+Tuttle+KR%2C+Short+RA%2C+Glushakova+O%2C+Ouyang+X%2C+Feig+DI%2C+Block+ER%2C+Herrera-Acosta+J%2C+Patel+JM%2C+Johnson+RJ&amp;rft.au=Nakagawa+T%2C+Hu+H%2C+Zharikov+S%2C+Tuttle+KR%2C+Short+RA%2C+Glushakova+O%2C+Ouyang+X%2C+Feig+DI%2C+Block+ER%2C+Herrera-Acosta+J%2C+Patel+JM%2C+Johnson+RJ&amp;rft.date=2006&amp;rft.volume=290&amp;rft.issue=3&amp;rft.pages=F625%26ndash%3BF631&amp;rft_id=info:doi/10.1152%2Fajprenal.00140.2005&amp;rft_id=info:pmid/16234313&amp;rfr_id=info:sid/en.wikipedia.org:Metabolic_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-13"><b><a href="#cite_ref-13" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHallfrisch_J1990">Hallfrisch J (1990). "Metabolic effects of dietary fructose". <i>FASEB J</i> <b>4</b> (9): 2652–2660. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2189777" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/2189777">PMID 2189777</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metabolic+effects+of+dietary+fructose&amp;rft.jtitle=FASEB+J&amp;rft.aulast=Hallfrisch+J&amp;rft.au=Hallfrisch+J&amp;rft.date=1990&amp;rft.volume=4&amp;rft.issue=9&amp;rft.pages=2652%26ndash%3B2660&amp;rft_id=info:pmid/2189777&amp;rfr_id=info:sid/en.wikipedia.org:Metabolic_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-14"><b><a href="#cite_ref-14" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFReiser_S.2C_Powell_AS.2C_Scholfield_DJ.2C_Panda_P.2C_Ellwood_KC.2C_Canary_JJ1989">Reiser S, Powell AS, Scholfield DJ, Panda P, Ellwood KC, Canary JJ (1989). "Blood lipids, lipoproteins, apoproteins, and uric acid in men fed diets containing fructose or high-amylose cornstarch". <i>Am J Clin Nutr</i> <b>49</b> (5): 832–839. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2497634" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/2497634">PMID 2497634</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Blood+lipids%2C+lipoproteins%2C+apoproteins%2C+and+uric+acid+in+men+fed+diets+containing+fructose+or+high-amylose+cornstarch&amp;rft.jtitle=Am+J+Clin+Nutr&amp;rft.aulast=Reiser+S%2C+Powell+AS%2C+Scholfield+DJ%2C+Panda+P%2C+Ellwood+KC%2C+Canary+JJ&amp;rft.au=Reiser+S%2C+Powell+AS%2C+Scholfield+DJ%2C+Panda+P%2C+Ellwood+KC%2C+Canary+JJ&amp;rft.date=1989&amp;rft.volume=49&amp;rft.issue=5&amp;rft.pages=832%26ndash%3B839&amp;rft_id=info:pmid/2497634&amp;rfr_id=info:sid/en.wikipedia.org:Metabolic_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-15"><b><a href="#cite_ref-15" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFukuchi_S.2C_Hamaguchi_K.2C_Seike_M.2C_Himeno_K.2C_Sakata_T.2C_Yoshimatsu_H.2004">Fukuchi S, Hamaguchi K, Seike M, Himeno K, Sakata T, Yoshimatsu H. (2004). "<a href="http://www.ebmonline.org/cgi/content/full/229/6/486" class="external text" title="http://www.ebmonline.org/cgi/content/full/229/6/486" rel="nofollow">Role of Fatty Acid Composition in the Development of Metabolic Disorders in Sucrose-Induced Obese Rats</a>". <i>Exp Biol Med</i> <b>229</b> (6): 486–493. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15169967" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15169967">PMID 15169967</a><span class="printonly">. <a href="http://www.ebmonline.org/cgi/content/full/229/6/486" class="external free" title="http://www.ebmonline.org/cgi/content/full/229/6/486" rel="nofollow">http://www.ebmonline.org/cgi/content/full/229/6/486</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Role+of+Fatty+Acid+Composition+in+the+Development+of+Metabolic+Disorders+in+Sucrose-Induced+Obese+Rats&amp;rft.jtitle=Exp+Biol+Med&amp;rft.aulast=Fukuchi+S%2C+Hamaguchi+K%2C+Seike+M%2C+Himeno+K%2C+Sakata+T%2C+Yoshimatsu+H.&amp;rft.au=Fukuchi+S%2C+Hamaguchi+K%2C+Seike+M%2C+Himeno+K%2C+Sakata+T%2C+Yoshimatsu+H.&amp;rft.date=2004&amp;rft.volume=229&amp;rft.issue=6&amp;rft.pages=486%26ndash%3B493&amp;rft_id=info:pmid/15169967&amp;rft_id=http%3A%2F%2Fwww.ebmonline.org%2Fcgi%2Fcontent%2Ffull%2F229%2F6%2F486&amp;rfr_id=info:sid/en.wikipedia.org:Metabolic_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-isbn0-07-147692-X-16">^ <a href="#cite_ref-isbn0-07-147692-X_16-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-isbn0-07-147692-X_16-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-isbn0-07-147692-X_16-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-isbn0-07-147692-X_16-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-isbn0-07-147692-X_16-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-isbn0-07-147692-X_16-5" title=""><sup><i><b>f</b></i></sup></a> <cite style="font-style:normal" class="book" id="CITEREFFauci.2C_Anthony_S.2008">Fauci, Anthony S. (2008). <i>Harrison's principles of internal medicine</i>. McGraw-Hill Medical. <a href="/wiki/Special:BookSources/007147692X" class="internal">ISBN 0-07-147692-X</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Harrison%27s+principles+of+internal+medicine&amp;rft.aulast=Fauci%2C+Anthony+S.&amp;rft.au=Fauci%2C+Anthony+S.&amp;rft.date=2008&amp;rft.pub=McGraw-Hill+Medical&amp;rft.isbn=0-07-147692-X&amp;rfr_id=info:sid/en.wikipedia.org:Metabolic_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17495599-17"><b><a href="#cite_ref-pmid17495599_17-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLara-Castro_C.2C_Fu_Y.2C_Chung_BH.2C_Garvey_WT2007">Lara-Castro C, Fu Y, Chung BH, Garvey WT (June 2007). "<a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00041433-200706000-00007" class="external text" title="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00041433-200706000-00007" rel="nofollow">Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease</a>". <i><a href="/w/index.php?title=Curr._Opin._Lipidol.&amp;action=edit&amp;redlink=1" class="new" title="Curr. Opin. Lipidol. (page does not exist)">Curr. Opin. Lipidol.</a></i> <b>18</b> (3): 263–70. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2FMOL.0b013e32814a645f" class="external text" title="http://dx.doi.org/10.1097%2FMOL.0b013e32814a645f" rel="nofollow">10.1097/MOL.0b013e32814a645f</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17495599" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17495599">PMID 17495599</a><span class="printonly">. <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00041433-200706000-00007" class="external free" title="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00041433-200706000-00007" rel="nofollow">http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00041433-200706000-00007</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Adiponectin+and+the+metabolic+syndrome%3A+mechanisms+mediating+risk+for+metabolic+and+cardiovascular+disease&amp;rft.jtitle=%5B%5BCurr.+Opin.+Lipidol.%5D%5D&amp;rft.aulast=Lara-Castro+C%2C+Fu+Y%2C+Chung+BH%2C+Garvey+WT&amp;rft.au=Lara-Castro+C%2C+Fu+Y%2C+Chung+BH%2C+Garvey+WT&amp;rft.date=June+2007&amp;rft.volume=18&amp;rft.issue=3&amp;rft.pages=263%E2%80%9370&amp;rft_id=info:doi/10.1097%2FMOL.0b013e32814a645f&amp;rft_id=info:pmid/17495599&amp;rft_id=http%3A%2F%2Fmeta.wkhealth.com%2Fpt%2Fpt-core%2Ftemplate-journal%2Flwwgateway%2Fmedia%2Flandingpage.htm%3Fan%3D00041433-200706000-00007&amp;rfr_id=info:sid/en.wikipedia.org:Metabolic_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid19258676-18"><b><a href="#cite_ref-pmid19258676_18-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRenaldi_O.2C_Pramono_B.2C_Sinorita_H.2C_Purnomo_LB.2C_Asdie_RH.2C_Asdie_AH2009">Renaldi O, Pramono B, Sinorita H, Purnomo LB, Asdie RH, Asdie AH (January 2009). "Hypoadiponectinemia: a risk factor for metabolic syndrome". <i><a href="/w/index.php?title=Acta_Med_Indones&amp;action=edit&amp;redlink=1" class="new" title="Acta Med Indones (page does not exist)">Acta Med Indones</a></i> <b>41</b> (1): 20–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1267%2Fscience.040579197" class="external text" title="http://dx.doi.org/10.1267%2Fscience.040579197" rel="nofollow">10.1267/science.040579197</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19258676" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/19258676">PMID 19258676</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Hypoadiponectinemia%3A+a+risk+factor+for+metabolic+syndrome&amp;rft.jtitle=%5B%5BActa+Med+Indones%5D%5D&amp;rft.aulast=Renaldi+O%2C+Pramono+B%2C+Sinorita+H%2C+Purnomo+LB%2C+Asdie+RH%2C+Asdie+AH&amp;rft.au=Renaldi+O%2C+Pramono+B%2C+Sinorita+H%2C+Purnomo+LB%2C+Asdie+RH%2C+Asdie+AH&amp;rft.date=January+2009&amp;rft.volume=41&amp;rft.issue=1&amp;rft.pages=20%E2%80%934&amp;rft_id=info:doi/10.1267%2Fscience.040579197&amp;rft_id=info:pmid/19258676&amp;rfr_id=info:sid/en.wikipedia.org:Metabolic_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-19"><b><a href="#cite_ref-19" title="">^</a></b> The IDF consensus worldwide definition of the metabolic syndrome. <a href="http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf" class="external text" title="http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf" rel="nofollow">PDF</a></li>
<li id="cite_note-20"><b><a href="#cite_ref-20" title="">^</a></b> Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. <i>Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).</i> JAMA 2001;285:2486-97. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11368702" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11368702">PMID 11368702</a>.</li>
<li id="cite_note-Grundy-21"><b><a href="#cite_ref-Grundy_21-0" title="">^</a></b> <a href="http://circ.ahajournals.org/cgi/reprint/109/3/433.pdf" class="external text" title="http://circ.ahajournals.org/cgi/reprint/109/3/433.pdf" rel="nofollow">Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant D, for the Conference Participants. Definition of metabolic syndrome: report of the National, Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.</a> Circulation. 2004;109:433-438.</li>
<li id="cite_note-22"><b><a href="#cite_ref-22" title="">^</a></b> <a href="http://www.americanheart.org/presenter.jhtml?identifier=4756" class="external text" title="http://www.americanheart.org/presenter.jhtml?identifier=4756" rel="nofollow">American Heart Association's description of Syndrome X</a></li>
<li id="cite_note-pmid19271113-23"><b><a href="#cite_ref-pmid19271113_23-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKogiso_T.2C_Moriyoshi_Y.2C_Shimizu_S.2C_Nagahara_H.2C_Shiratori_K2009">Kogiso T, Moriyoshi Y, Shimizu S, Nagahara H, Shiratori K (March 2009). "High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike Information Criterion scoring system in the general Japanese population". <i><a href="/w/index.php?title=J._Gastroenterol.&amp;action=edit&amp;redlink=1" class="new" title="J. Gastroenterol. (page does not exist)">J. Gastroenterol.</a></i>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs00535-009-0002-5" class="external text" title="http://dx.doi.org/10.1007%2Fs00535-009-0002-5" rel="nofollow">10.1007/s00535-009-0002-5</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19271113" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/19271113">PMID 19271113</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=High-sensitivity+C-reactive+protein+as+a+serum+predictor+of+nonalcoholic+fatty+liver+disease+based+on+the+Akaike+Information+Criterion+scoring+system+in+the+general+Japanese+population&amp;rft.jtitle=%5B%5BJ.+Gastroenterol.%5D%5D&amp;rft.aulast=Kogiso+T%2C+Moriyoshi+Y%2C+Shimizu+S%2C+Nagahara+H%2C+Shiratori+K&amp;rft.au=Kogiso+T%2C+Moriyoshi+Y%2C+Shimizu+S%2C+Nagahara+H%2C+Shiratori+K&amp;rft.date=March+2009&amp;rft_id=info:doi/10.1007%2Fs00535-009-0002-5&amp;rft_id=info:pmid/19271113&amp;rfr_id=info:sid/en.wikipedia.org:Metabolic_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-24"><b><a href="#cite_ref-24" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLakka_TA.2C_Laaksonen_DE2007">Lakka TA, Laaksonen DE (2007). "Physical activity in prevention and treatment of the metabolic syndrome". <i>Applied physiology, nutrition, and metabolism = Physiologie appliquée, nutrition et métabolisme</i> <b>32</b> (1): 76–88. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1139%2Fh06-113" class="external text" title="http://dx.doi.org/10.1139%2Fh06-113" rel="nofollow">10.1139/h06-113</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17332786" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17332786">PMID 17332786</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Physical+activity+in+prevention+and+treatment+of+the+metabolic+syndrome&amp;rft.jtitle=Applied+physiology%2C+nutrition%2C+and+metabolism+%3D+Physiologie+appliqu%C3%A9e%2C+nutrition+et+m%C3%A9tabolisme&amp;rft.aulast=Lakka+TA%2C+Laaksonen+DE&amp;rft.au=Lakka+TA%2C+Laaksonen+DE&amp;rft.date=2007&amp;rft.volume=32&amp;rft.issue=1&amp;rft.pages=76%E2%80%9388&amp;rft_id=info:doi/10.1139%2Fh06-113&amp;rft_id=info:pmid/17332786&amp;rfr_id=info:sid/en.wikipedia.org:Metabolic_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-25"><b><a href="#cite_ref-25" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFeldeisen_SE.2C_Tucker_KL2007">Feldeisen SE, Tucker KL (2007). "Nutritional strategies in the prevention and treatment of metabolic syndrome". <i>Appl Physiol Nutr Metab</i> <b>32</b> (1): 46–60. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1139%2Fh06-101" class="external text" title="http://dx.doi.org/10.1139%2Fh06-101" rel="nofollow">10.1139/h06-101</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17332784" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17332784">PMID 17332784</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Nutritional+strategies+in+the+prevention+and+treatment+of+metabolic+syndrome&amp;rft.jtitle=Appl+Physiol+Nutr+Metab&amp;rft.aulast=Feldeisen+SE%2C+Tucker+KL&amp;rft.au=Feldeisen+SE%2C+Tucker+KL&amp;rft.date=2007&amp;rft.volume=32&amp;rft.issue=1&amp;rft.pages=46%E2%80%9360&amp;rft_id=info:doi/10.1139%2Fh06-101&amp;rft_id=info:pmid/17332784&amp;rfr_id=info:sid/en.wikipedia.org:Metabolic_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-katzmaryk-26">^ <a href="#cite_ref-katzmaryk_26-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-katzmaryk_26-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFKatzmaryk.2CLeon.2C_Arthur_S..3B_Wilmore.2C_Jack_H..3B_Skinner.2C_James_S..3B_Rao.2C_D._C..3B_Rankinen.2C_Tuomo.3B_Bouchard.2C_Claude">Katzmaryk,, Peter T; Leon, Arthur S.; Wilmore, Jack H.; Skinner, James S.; Rao, D. C.; Rankinen, Tuomo; Bouchard, Claude (<a href="/wiki/October_2003" title="October 2003">October 2003</a>). "<a href="http://www.ms-se.com/pt/re/msse/abstract.00005768-200310000-00013.htm" class="external text" title="http://www.ms-se.com/pt/re/msse/abstract.00005768-200310000-00013.htm" rel="nofollow">Targeting the Metabolic Syndrome with Exercise: Evidence from the HERITAGE Family Study.</a>". <i>Med. Sci. Sports Exerc</i> <b>35</b> (10): 1703–1709. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1249%2F01.MSS.0000089337.73244.9B" class="external text" title="http://dx.doi.org/10.1249%2F01.MSS.0000089337.73244.9B" rel="nofollow">10.1249/01.MSS.0000089337.73244.9B</a></span><span class="printonly">. <a href="http://www.ms-se.com/pt/re/msse/abstract.00005768-200310000-00013.htm" class="external free" title="http://www.ms-se.com/pt/re/msse/abstract.00005768-200310000-00013.htm" rel="nofollow">http://www.ms-se.com/pt/re/msse/abstract.00005768-200310000-00013.htm</a></span><span class="reference-accessdate">. Retrieved on 2007-06-24</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Targeting+the+Metabolic+Syndrome+with+Exercise%3A+Evidence+from+the+HERITAGE+Family+Study.&amp;rft.jtitle=Med.+Sci.+Sports+Exerc&amp;rft.aulast=Katzmaryk%2C&amp;rft.aufirst=Peter+T&amp;rft.au=Katzmaryk%2C%2C+Peter+T&amp;rft.au=Leon%2C+Arthur+S.%3B+Wilmore%2C+Jack+H.%3B+Skinner%2C+James+S.%3B+Rao%2C+D.+C.%3B+Rankinen%2C+Tuomo%3B+Bouchard%2C+Claude&amp;rft.date=%5B%5BOctober+2003%5D%5D&amp;rft.volume=35&amp;rft.issue=10&amp;rft.pages=1703%E2%80%931709&amp;rft_id=info:doi/10.1249%2F01.MSS.0000089337.73244.9B&amp;rft_id=http%3A%2F%2Fwww.ms-se.com%2Fpt%2Fre%2Fmsse%2Fabstract.00005768-200310000-00013.htm&amp;rfr_id=info:sid/en.wikipedia.org:Metabolic_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-27"><b><a href="#cite_ref-27" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJames_PT.2C_Rigby_N.2C_Leach_R2004">James PT, Rigby N, Leach R (2004). "The obesity epidemic, metabolic syndrome and future prevention strategies". <i>Eur J Cardiovasc Prev Rehabil</i> <b>11</b> (1): 3–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F01.hjr.0000114707.27531.48" class="external text" title="http://dx.doi.org/10.1097%2F01.hjr.0000114707.27531.48" rel="nofollow">10.1097/01.hjr.0000114707.27531.48</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15167200" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15167200">PMID 15167200</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+obesity+epidemic%2C+metabolic+syndrome+and+future+prevention+strategies&amp;rft.jtitle=Eur+J+Cardiovasc+Prev+Rehabil&amp;rft.aulast=James+PT%2C+Rigby+N%2C+Leach+R&amp;rft.au=James+PT%2C+Rigby+N%2C+Leach+R&amp;rft.date=2004&amp;rft.volume=11&amp;rft.issue=1&amp;rft.pages=3%E2%80%938&amp;rft_id=info:doi/10.1097%2F01.hjr.0000114707.27531.48&amp;rft_id=info:pmid/15167200&amp;rfr_id=info:sid/en.wikipedia.org:Metabolic_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-28"><b><a href="#cite_ref-28" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFElwoodPickering_JE.2C_Fehily_AM2007">Elwood, PC; Pickering JE, Fehily AM (2007). "<a href="http://jech.bmj.com/cgi/content/abstract/61/8/695" class="external text" title="http://jech.bmj.com/cgi/content/abstract/61/8/695" rel="nofollow">Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study</a>". <i>J Epidemiol Community Health</i> <b>61</b> (8): 695–698. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fjech.2006.053157" class="external text" title="http://dx.doi.org/10.1136%2Fjech.2006.053157" rel="nofollow">10.1136/jech.2006.053157</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17630368" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17630368">PMID 17630368</a><span class="printonly">. <a href="http://jech.bmj.com/cgi/content/abstract/61/8/695" class="external free" title="http://jech.bmj.com/cgi/content/abstract/61/8/695" rel="nofollow">http://jech.bmj.com/cgi/content/abstract/61/8/695</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Milk+and+dairy+consumption%2C+diabetes+and+the+metabolic+syndrome%3A+the+Caerphilly+prospective+study&amp;rft.jtitle=J+Epidemiol+Community+Health&amp;rft.aulast=Elwood&amp;rft.aufirst=PC&amp;rft.au=Elwood%2C+PC&amp;rft.au=Pickering+JE%2C+Fehily+AM&amp;rft.date=2007&amp;rft.volume=61&amp;rft.issue=8&amp;rft.pages=695%E2%80%93698&amp;rft_id=info:doi/10.1136%2Fjech.2006.053157&amp;rft_id=info:pmid/17630368&amp;rft_id=http%3A%2F%2Fjech.bmj.com%2Fcgi%2Fcontent%2Fabstract%2F61%2F8%2F695&amp;rfr_id=info:sid/en.wikipedia.org:Metabolic_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-29"><b><a href="#cite_ref-29" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSnijder_MB.2C_van_der_Heijden_AA.2C_van_Dam_RM.2C_.27.27et_al.27.272007">Snijder MB, van der Heijden AA, van Dam RM, <i>et al</i> (2007). "Is higher dairy consumption associated with lower body weight and fewer metabolic disturbances? The Hoorn Study". <i>Am. J. Clin. Nutr.</i> <b>85</b> (4): 989–95. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17413097" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17413097">PMID 17413097</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Is+higher+dairy+consumption+associated+with+lower+body+weight+and+fewer+metabolic+disturbances%3F+The+Hoorn+Study&amp;rft.jtitle=Am.+J.+Clin.+Nutr.&amp;rft.aulast=Snijder+MB%2C+van+der+Heijden+AA%2C+van+Dam+RM%2C+%27%27et+al%27%27&amp;rft.au=Snijder+MB%2C+van+der+Heijden+AA%2C+van+Dam+RM%2C+%27%27et+al%27%27&amp;rft.date=2007&amp;rft.volume=85&amp;rft.issue=4&amp;rft.pages=989%E2%80%9395&amp;rft_id=info:pmid/17413097&amp;rfr_id=info:sid/en.wikipedia.org:Metabolic_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-30"><b><a href="#cite_ref-30" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRichard_Kahn2008">Richard Kahn (2008). "Metabolic syndrome—what is the clinical usefulness?". <i>Lancet</i> <b>371</b>: 1892–1893. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2808%2960731-X" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2808%2960731-X" rel="nofollow">10.1016/S0140-6736(08)60731-X</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metabolic+syndrome%E2%80%94what+is+the+clinical+usefulness%3F&amp;rft.jtitle=Lancet&amp;rft.aulast=Richard+Kahn&amp;rft.au=Richard+Kahn&amp;rft.date=2008&amp;rft.volume=371&amp;rft.pages=1892%26ndash%3B1893&amp;rft_id=info:doi/10.1016%2FS0140-6736%2808%2960731-X&amp;rfr_id=info:sid/en.wikipedia.org:Metabolic_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-31"><b><a href="#cite_ref-31" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKahn_R.2C_Buse_J.2C_Ferrannini_E.2C_Stern_M2005">Kahn R, Buse J, Ferrannini E, Stern M (2005). "The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes". <i>Diabetes Care</i> <b>28</b>: 2289–2304. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2337%2Fdiacare.28.9.2289" class="external text" title="http://dx.doi.org/10.2337%2Fdiacare.28.9.2289" rel="nofollow">10.2337/diacare.28.9.2289</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16123508" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16123508">PMID 16123508</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+metabolic+syndrome%3A+time+for+a+critical+appraisal.+Joint+statement+from+the+American+Diabetes+Association+and+the+European+Association+for+the+Study+of+Diabetes&amp;rft.jtitle=Diabetes+Care&amp;rft.aulast=Kahn+R%2C+Buse+J%2C+Ferrannini+E%2C+Stern+M&amp;rft.au=Kahn+R%2C+Buse+J%2C+Ferrannini+E%2C+Stern+M&amp;rft.date=2005&amp;rft.volume=28&amp;rft.pages=2289%26ndash%3B2304&amp;rft_id=info:doi/10.2337%2Fdiacare.28.9.2289&amp;rft_id=info:pmid/16123508&amp;rfr_id=info:sid/en.wikipedia.org:Metabolic_syndrome"><span style="display: none;">&#160;</span></span></li>
</ol>
</div>
<p><span id="interwiki-it-fa"></span></p>


<!-- 
NewPP limit report
Preprocessor node count: 8778/1000000
Post-expand include size: 78134/2048000 bytes
Template argument size: 28324/2048000 bytes
Expensive parser function count: 1/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:54439-0!1!0!default!!en!2 and timestamp 20090406232551 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Metabolic_syndrome">http://en.wikipedia.org/wiki/Metabolic_syndrome</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Diabetes" title="Category:Diabetes">Diabetes</a></span> | <span dir='ltr'><a href="/wiki/Category:Endocrinology" title="Category:Endocrinology">Endocrinology</a></span> | <span dir='ltr'><a href="/wiki/Category:Medical_conditions_related_to_obesity" title="Category:Medical conditions related to obesity">Medical conditions related to obesity</a></span> | <span dir='ltr'><a href="/wiki/Category:Syndromes" title="Category:Syndromes">Syndromes</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_August_2007" title="Category:Articles with unsourced statements since August 2007">Articles with unsourced statements since August 2007</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Metabolic_syndrome" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Metabolic_syndrome" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Metabolic_syndrome&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Metabolic_syndrome" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Metabolic_syndrome" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Metabolic_syndrome" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Metabolic_syndrome&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Metabolic_syndrome&amp;oldid=277276395" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Metabolic_syndrome&amp;id=277276395">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-bg"><a href="http://bg.wikipedia.org/wiki/%D0%9C%D0%B5%D1%82%D0%B0%D0%B1%D0%BE%D0%BB%D0%B8%D1%82%D0%B5%D0%BD_%D1%81%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC">Български</a></li>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Metabolisches_Syndrom">Deutsch</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/S%C3%ADndrome_metab%C3%B3lico">Español</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Syndrome_m%C3%A9tabolique">Français</a></li>
				<li class="interwiki-ko"><a href="http://ko.wikipedia.org/wiki/%EB%8C%80%EC%82%AC_%EC%A6%9D%ED%9B%84%EA%B5%B0">한국어</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Sindrome_metabolica">Italiano</a></li>
				<li class="interwiki-he"><a href="http://he.wikipedia.org/wiki/%D7%94%D7%AA%D7%A1%D7%9E%D7%95%D7%A0%D7%AA_%D7%94%D7%9E%D7%98%D7%91%D7%95%D7%9C%D7%99%D7%AA">עברית</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Metabool_syndroom">Nederlands</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E3%83%A1%E3%82%BF%E3%83%9C%E3%83%AA%E3%83%83%E3%82%AF%E3%82%B7%E3%83%B3%E3%83%89%E3%83%AD%E3%83%BC%E3%83%A0">日本語</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Zesp%C3%B3%C5%82_metaboliczny">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/S%C3%ADndrome_metab%C3%B3lica">Português</a></li>
				<li class="interwiki-ru"><a href="http://ru.wikipedia.org/wiki/%D0%9C%D0%B5%D1%82%D0%B0%D0%B1%D0%BE%D0%BB%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B9_%D1%81%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC">Русский</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Metabolinen_oireyhtym%C3%A4">Suomi</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Metabolt_syndrom">Svenska</a></li>
				<li class="interwiki-zh"><a href="http://zh.wikipedia.org/wiki/%E4%BB%A3%E8%AC%9D%E7%97%87%E5%80%99%E7%BE%A4">中文</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 14 March 2009, at 22:52.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv111 in 2.286 secs. --></body></html>
